Human Genome Epidemiology Literature Finder
Filtered By: |
Previous |
Records 1 - 4 (of 4 Records) |
Query Trace: Atherosclerosis and CYP2C9[original query] |
---|
Role of CYP2C9 and CYP2C19 polymorphisms in patients with atherosclerosis. Cell biochemistry and function 2008 Apr 26 (3): 309-13. Ercan B, Ayaz L, Ciçek D, Tamer |
Common polymorphisms in CYP2C9, subclinical atherosclerosis and risk of ischemic vascular disease in 52,000 individuals. The pharmacogenomics journal 2009 Oct 9 (5): 327-32. Kaur-Knudsen D, Bojesen S E, Nordestgaard B |
Increased warfarin consumption and residual fibrin turnover in thrombotic patients with primary antiphospholipid syndrome. Thrombosis research 2011 Jun 127 (6): 595-9. Ames Paul R J, Margaglione Maurizio, Ciampa Antonio, Colaizzo Donatella, Ferrara Felicetto, Iannaccone Luigi, Vincenzobrancacci |
Role of CYP2C9 polymorphism in phenytoin-related metabolic abnormalities and subclinical atherosclerosis in young adult epileptic patients. Seizure : the journal of the British Epilepsy Association 2012 Nov . Phabphal K, Geater A, Limapichart K, Sathirapanya P, Setthawatcharawanich S |
- Page last reviewed:Feb 1, 2024
- Content source: